-
Louis's Most Popular
-
Articles
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 87 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
When It’s Time to “Cut and Run” on a Strong Stock
In yesterday’ Market360, I showed you an example of when it’s a good idea to let a fundamentally superior stock like BioNTech SE (NASDAQ:BNTX) keep…
EV News Dominates Headlines
Electric vehicle (EV) news has been dominating headlines for the past few weeks. Between President Joe Biden’s new EV executive order, EV sales surging in…
Why This Fundamentally Superior Biotech Is Soaring
This biotech stock has had a good run-up as of late. But does that mean it should be the only one you invest in? Nope. And here's why.
My Thoughts on AMC’s Second-Quarter Earnings Report
Reddit-favorite AMC Entertainment Holdings unveiled its second-quarter earnings results on Monday. That said, let's take a closer look.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 100 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Major Earnings Results from This Week
Last week was another busy earnings week for Wall Street, so let’s review some of the highlights in this version of Market360.
Why These Biotech Stocks Are Soaring
There’s major potential for all of these biotech stocks, especially after full FDA approval, but this one stands to be one of the top winners.
Why the Stock Market is Going to Continue Climbing Higher
We are only in the fourth inning of a robust economic recovery, and here's why the stock market is going to continue to meander higher.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 114 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Should You Invest in Robinhood?
After the recent Robinhood IPO, here is how I feel about you and other investors buying shares of HOOD stock from now on.
Why the Decline in Treasury Yields Is Bullish for Growth Stocks
I can't emphasize enough how bullish the recent decline in Treasury bond yields is for the stock market -- especially for these stocks.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 132 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
The Profit Potential Behind Zoom’s Latest Growth Plans
Virtual meetings have been vital to maintain business operations during the pandemic. And their importance isn’t going away anytime soon.
Why This Company’s Covid-19 Vaccine Is Just the Beginning
It’s little surprise that some of the companies behind the Covid-19 vaccines have seen their stocks rise. Here's how investors can benefit.
Ignore Wall Street’s Mania — Focus on These 2 Market Catalysts Instead
The main catalyst behind yesterday’s selling was over the Covid-19 delta variant. But here's why there's more to take into account.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 104 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
